Continued Atezolizumab Shows Durable Benefit in Pretreated ES-SCLC“Continuation therapy with atezolizumab (Tecentriq) following progression on first-line chemo-immunotherapy produced promising efficacy and manageable safety in a small cohort of patients with...
For cancer patients, oncologists often have the final word“For terminally ill cancer patients, the final days of life are immensely personal, having the choice to continue cancer treatments, or to stop treatments and prioritize a more comfortable passing. What a...
Mays Cancer Center continues collaboration with American Cancer Society to expand lung cancer screenings“Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is proud to announce the American Cancer Society’s...
2 Immunotherapies Show Comparable Benefits in Extensive-Stage Small Cell Lung Cancer“Key Takeaways: PD-1 and PD-L1 inhibitors combined with chemotherapy significantly improve survival in ES-SCLC compared with chemotherapy alone. No significant difference in overall...
Lung Cancer Among Non-Smokers Increasing“Rates of lung cancer diagnoses among people who have never smoked are rising, according to the World Health Organization’s cancer agency. The International Agency for Research on Cancer (IARC) estimates that lung cancer is now...
Does Your Home Harbor a Killer?“HIGH POINT, N.C., Jan. 28, 2025 /PRNewswire/ — January is Radon Action Month, a vital time for individuals and communities to learn about radon risks and take action. This week, designated as National Radon Awareness Week by the...
More News and Updates